Patient perspectives when switching from Cosopt<sup>&reg;</sup> (dorzolamide-timolol) to Azarga&trade; (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Graham Anthony Auger; Mathew Raynor; Simon Longstaff

doi:10.2147/OPTH.S33254

open access to scientific and medical research

Back to Journals » Clinical Ophthalmology » Volume 6

Original Research

Patient perspectives when switching from Cosopt^® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Total article views		HTML views	PDF downloads	Totals
14,126	Dovepress*	11,548+	1,774	13,322
	PubMed Central*	2,578	434	3,012
	Totals	14,126	2,208	16,334
*Since 11 December 2012 +Since July 2016

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Patient perspectives when switching from Cosopt^® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy